Company Profiles

driven by the PitchBook Platform

Artax Biopharma

Description

Developer of next generation therapies designed to serve the patients of autoimmune and inflammatory diseases. The company's next generation therapies discover new variety of drugs that target the interaction point between T-cell Receptors (TCR) and Nck, enabling patients to get themselves cured from wide range of autoimmune and inflammatory diseases.

2013

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$10M

Latest Deal Amount

$12M

Total Amount Raised

Description

Developer of next generation therapies designed to serve the patients of autoimmune and inflammatory diseases. The company's next generation therapies discover new variety of drugs that target the interaction point between T-cell Receptors (TCR) and Nck, enabling patients to get themselves cured from wide range of autoimmune and inflammatory diseases.

Website:

www.artaxbiopharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Pharmaceuticals

Primary Office

1 Broadway, 14th floor Cambridge, MA 02142United States +1 (617) 330-7000
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Artax Biopharma's full profile, request a free trial.

Artax Biopharma Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Artax Biopharma Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Artax Biopharma Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Advent Life SciencesVenture CapitalMinority000 0000000 0000
A. M. Pappas & AssociatesOtherMinority000 0000000 0000
Henri TermeerAngel (individual)Minority000 0000000 0000
Advent Life Sciences Venture Capital
A. M. Pappas & Associates Other
Henri Termeer Angel (individual)

Artax Biopharma Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Luc Marti Ph.DChief Operating Officer
Balbino Alarcón Ph.DChief Scientific Officer
Andy Gagete Ph.DDirector, Research & Development
Damià Tormo Ph.DCo-Founder, Board Member & Chief Executive Officer
Thomas McGauleyChief Financial Officer
Luc Marti Ph.D Chief Operating Officer
Balbino Alarcón Ph.D Chief Scientific Officer
Andy Gagete Ph.D Director, Research & Development
Damià Tormo Ph.D Co-Founder, Board Member & Chief Executive Officer
Thomas McGauley Chief Financial Officer

Artax Biopharma Board Members (6)

NameRepresentingRoleSinceContact
Info
Damià Tormo Ph.DSelfCo-Founder, Board Member & Chief Executive Officer000 0000
Gino SantiniSelfBoard Member000 0000
Henri Termeer Ph.DSelfBoard Member000 0000
Javier GarcíaArtax BiopharmaBoard Member & Executive, Business Development000 0000
Rajesh Parekh Ph.DAdvent Life SciencesGeneral Partner000 0000
Damià Tormo Ph.D Co-Founder, Board Member & Chief Executive Officer Self
Gino Santini Board Member Self
Henri Termeer Ph.D Board Member Self
Javier García Board Member & Executive, Business Development Artax Biopharma
Rajesh Parekh Ph.D General Partner Advent Life Sciences
Request full access to PitchBook